Dynamic phosphorus-31 magnetic resonance spectroscopy in arterial occlusive disease: Effects of vascular therapy on spectroscopic results

Investigative Radiology

Volumn 33, Issue 6, 1998, Pages 329-335

  Schunk, Klaus ^a   Romaneehsen, Bernd ^a   Rieker, Olaf ^a   Düber, Christoph ^a   Kersjes, Wilhelm ^a   Schadmand Fischer, Simin ^a   Schmiedt, Walter ^a   Thelen, Manfred ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Arterial occlusive disease; Magnetic resonance spectroscopy; Muscular metabolism; Phosphorus 31; Quadriceps muscle; Vascular therapy

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; PHOSPHATE;

ADULT; AGED; ANAEROBIC GLYCOLYSIS; ARTERIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; EXERCISE; FEMALE; HUMAN; MALE; MUSCLE METABOLISM; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE;

EID: 0031863397     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199806000-00003     Document Type: Article

References (30)

1. 31phosphorus magnetic resonance spectroscopy of the Quadriceps muscle: Metabolic changes resulting from two different forms of exercise. Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 1997;166:317-323.
2. Schunk K, Romaneehsen B, Mildenberger P, Kersjes W, SchadmandFischer S, Thelen M. Dynamic phosphorus-31 magnetic resonance spectroscopy in arterial occlusive disease: Correlation with clinical and angiographic findings and comparison to healthy volunteers. Invest Radiol 1997;32:651-659.
3. 31P-MRS and simultaneous quantification of dynamic human quadriceps exercise in a whole body MR scanner. J Appl Physiol 1994;77:1021-1029.
4. Kaltenborn H. Angiographie der distalen abdominellen Aorta, des Beckens und der unteren Extremität. In Schild H. Angiographie-angiographische Interventionen. New York: Georg Thieme Verlag-Stuttgart, 1994.
5. 31P NMR spectroscopy and EMG in exercising and recovering human skeletal muscle: Technical aspects. Magn Reson Med 1994;31:93-102.
6. 1H-MR-Spektroskopie. Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 1990;153:209-215.
7. McCully KK, Boden BP, Tuchler M, Fountain MR, Chance B. Wrist flexor muscles of elite rowers measured with magnetic resonance spectroscopy. J Appl Physiol 1989;67:926-932.
8. 31P-NMR: Potential and limitations. In: Rudin M, ed. In vivo magnetic resonance spectroscopy III: In vivo MR spectroscopy: Potential and limitations. Berlin: Springer Verlag, 1992.
9. 1H magnetic resonance spectroscopic studies of skeletal muscle: An analytic review. Magn Reson Q 1994;10:43-63.
10. 31P magnetic resonance spectroscopy. Eur Radiol 1993;3:499-506.
11. King LE Jr, Park JH, Adams LB, Olsen NJ. Phosphorus 31 magnetic resonance spectroscopy for quantitative evaluation of therapeutic regimens in dermatomyositis. Arch Dermatol 1995;131:522-524.
12. King LE Jr, Olsen NJ, Puett D, Vital TL, Schulman M, Park JH. Quantitative evaluation of muscle weakness in scleroderma patients using magnetic resonance imaging and spectroscopy. Arch Dermatol 1993;129:246-247.
13. Marsh GD, McFadden RG, Nicholson RL, Thompson RT. Theophyl-line delays skeletal muscle fatigue during progressive exercise. Am Rev Respir Dis 1993;147:876-879.
14. Land JM, Kemp GJ, Taylor DJ, Standing SJ, Radda GK, Rajagopalan B. Oral phosphate supplements reverse skeletal muscle abnormalities in a case of chronic fatigue with idiopathic renal hypophosphatemia. Neuromuscul Disord 1993;3:223-225.
15. 31P nuclear magnetic resonance spectroscopy. Clin Sci 1986;71:283-290.
16. Keller U, Oberhänsli R, Huber P, et al. Phosphocreatine content and intracellular pH of calf muscle measured by phosphorus NMR spectroscopy in occlusive arterial disease of the legs. Eur J Clin Invest 1985;15:382-388.
17. Stratton JR, Kemp GJ, Daly RC, Yacoub M, Rajagopalan B. Effects of cardiac transplantation on bioenergetic abnormalities of skeletal muscle in congestive heart failure. Circulation 1994;89:1624-1631.
18. 31P NMR spectroscopy: Noninvasive biochemical analysis of the ischemic extremity. J Vasc Surg 1986;3:411-420.
19. Payen JF, Wuyam P, Levy P, et al. Muscular metabolism during oxygen supplementation in patients with chronic hypoxemia. Am Rev Respir Dis 1993;147:592-598.
20. Stratton JR, Dunn JF, Adamopoulos S, Kemp GJ, Coats AJ, Rajagopalan B. Training partially reverses skeletal muscle metabolic abnormalities during exercise in heart failure. J Appl Physiol 1994;76:1575-1582.
21. Terjung RL, Mathien GM, Erney TP, Ogilvie RW. Peripheral adaptations to low blood flow in muscle during exercise. Am J Cardiol 1988;62:15E-19E.
22. 31P nuclear magnetic resonance (NMR) spectroscopy. Therapie 1992;47:125-126.
23. 31Phosphor-MR-Spektroskopie der Wadenmuskulatur bei arterieller Verschjluβ-krankheit. Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 1992;156:346-352.
24. 31P NMR spectroscopy. Magn Reson Imaging 1994;12:1121-1126.
25. Marsh GD, Paterson DH, Thompson RT, Cheung PK, MacDermid J, Arnold JM. Metabolic adaptations to endurance training in older individuals. Can J Appl Physiol 1993;18:366-378.
26. 31P study. J Appl Physiol 1990;69:1165-1170.
27. 31 magnetic resonance spectroscopy. J Am Coll Cardiol 1986;7:793-799.
28. van der Grond J, Crolla RM, Ten Hove W, van Vroonhoven TJ, Mali WP. Phosphorus magnetic resonance spectroscopy of the calf muscle in patients with peripheral arterial occlusive disease. Invest Radiol 1993;28:104-108.
29. Adamopoulos S, Coats AJ, Brunotte F, et al. Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardiol 1993;21:1101-1106.
30. Kemp GJ, Thompson CH, Sanderson AL, Radda GK. pH control in rat skeletal muscle during exercise, recovery from exercise, and acute respiratory acidosis. Magn Reson Med 1994;31:103-109.